Prostate cancer has a long disease history and a wide variety and uncertainty in individual
patients' clinical progress. In recent years, we have seen a revolutionary advance in both …

Castration-resistant prostate cancer, or CRPC, is an aggressive stage of prostate cancer
(PCa) in which PCa cells invade nearby or other parts of the body. When a patient with PCa …

During the last decades, male urogenital cancers (including prostate, renal, bladder and
testicular cancers) have become one of the most frequently encountered malignancies …

Abstract Background Prostate cancer (PCa), one of the most prevalent malignancies
affecting men, significantly contributes to increased mortality rates worldwide. While the …

The atypical protein kinase/ATPase RIO kinase (RIOK)-1 is involved in pre-40S ribosomal
subunit production, cell-cycle progression, and protein arginine N-methyltransferase 5 …

Prostate cancer (PCa) is a complex and biologically diverse disease with no curative
treatment options at present. This study aims to utilize computational methods to explore …

Prostate cancer is a common malignancy in urology which often develops into
castrationresistant prostate cancer (CRPC) after hormone therapy. Studies have shown that …

Background: Early diagnosis remains a challenge for prostate cancer (PCa) due to
molecular heterogeneity. The purpose of our study was to explore the diagnostic potential of …

Abstract δ-Catenin is expressed abundantly in various human cancers, including prostate,
brain, breast, and lung carcinomas, and is recognized as an oncogene that promotes cancer …

Leptomeningeal metastasis/leptomeningeal carcinomatosis (LMC; terms used
interchangeably) is an inflammatory complication of primary tumors that involves the spread …